img

Global Prostacyclin Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prostacyclin Drug Market Insights, Forecast to 2034

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
Global Prostacyclin Drug market is expected to reach to US$ 2452.2 million in 2024, with a positive growth of %, compared with US$ 2367 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Prostacyclin Drug industry is evaluated to reach US$ 3102.8 million in 2029. The CAGR will be 4.0% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Prostacyclin Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Prostacyclin Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium

Segment by Application


For Injection
For Oral
For Inhalation

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Prostacyclin Drug plant distribution, commercial date of Prostacyclin Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Prostacyclin Drug introduction, etc. Prostacyclin Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Prostacyclin Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Prostacyclin Drug Product Introduction
1.2 Market by Type
1.2.1 Global Prostacyclin Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Epoprostenol Sodium
1.2.3 Treprostinil
1.2.4 Iloprost
1.2.5 Beraprost Sodium
1.3 Market by Application
1.3.1 Global Prostacyclin Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 For Injection
1.3.3 For Oral
1.3.4 For Inhalation
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Prostacyclin Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Prostacyclin Drug Revenue by Region
2.2.1 Global Prostacyclin Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Prostacyclin Drug Revenue by Region (2018-2024)
2.2.3 Global Prostacyclin Drug Revenue by Region (2024-2029)
2.2.4 Global Prostacyclin Drug Revenue Market Share by Region (2018-2029)
2.3 Global Prostacyclin Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Prostacyclin Drug Sales by Region
2.4.1 Global Prostacyclin Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Prostacyclin Drug Sales by Region (2018-2024)
2.4.3 Global Prostacyclin Drug Sales by Region (2024-2029)
2.4.4 Global Prostacyclin Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Prostacyclin Drug Sales by Manufacturers
3.1.1 Global Prostacyclin Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Prostacyclin Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostacyclin Drug in 2022
3.2 Global Prostacyclin Drug Revenue by Manufacturers
3.2.1 Global Prostacyclin Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Prostacyclin Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Prostacyclin Drug Revenue in 2022
3.3 Global Key Players of Prostacyclin Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Prostacyclin Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Prostacyclin Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Prostacyclin Drug, Product Offered and Application
3.8 Global Key Manufacturers of Prostacyclin Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prostacyclin Drug Sales by Type
4.1.1 Global Prostacyclin Drug Historical Sales by Type (2018-2024)
4.1.2 Global Prostacyclin Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Prostacyclin Drug Sales Market Share by Type (2018-2029)
4.2 Global Prostacyclin Drug Revenue by Type
4.2.1 Global Prostacyclin Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Prostacyclin Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Prostacyclin Drug Revenue Market Share by Type (2018-2029)
4.3 Global Prostacyclin Drug Price by Type
4.3.1 Global Prostacyclin Drug Price by Type (2018-2024)
4.3.2 Global Prostacyclin Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Prostacyclin Drug Sales by Application
5.1.1 Global Prostacyclin Drug Historical Sales by Application (2018-2024)
5.1.2 Global Prostacyclin Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Prostacyclin Drug Sales Market Share by Application (2018-2029)
5.2 Global Prostacyclin Drug Revenue by Application
5.2.1 Global Prostacyclin Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Prostacyclin Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Prostacyclin Drug Revenue Market Share by Application (2018-2029)
5.3 Global Prostacyclin Drug Price by Application
5.3.1 Global Prostacyclin Drug Price by Application (2018-2024)
5.3.2 Global Prostacyclin Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Prostacyclin Drug Market Size by Type
6.1.1 US & Canada Prostacyclin Drug Sales by Type (2018-2029)
6.1.2 US & Canada Prostacyclin Drug Revenue by Type (2018-2029)
6.2 US & Canada Prostacyclin Drug Market Size by Application
6.2.1 US & Canada Prostacyclin Drug Sales by Application (2018-2029)
6.2.2 US & Canada Prostacyclin Drug Revenue by Application (2018-2029)
6.3 US & Canada Prostacyclin Drug Market Size by Country
6.3.1 US & Canada Prostacyclin Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Prostacyclin Drug Sales by Country (2018-2029)
6.3.3 US & Canada Prostacyclin Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Prostacyclin Drug Market Size by Type
7.1.1 Europe Prostacyclin Drug Sales by Type (2018-2029)
7.1.2 Europe Prostacyclin Drug Revenue by Type (2018-2029)
7.2 Europe Prostacyclin Drug Market Size by Application
7.2.1 Europe Prostacyclin Drug Sales by Application (2018-2029)
7.2.2 Europe Prostacyclin Drug Revenue by Application (2018-2029)
7.3 Europe Prostacyclin Drug Market Size by Country
7.3.1 Europe Prostacyclin Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Prostacyclin Drug Sales by Country (2018-2029)
7.3.3 Europe Prostacyclin Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Prostacyclin Drug Market Size
8.1.1 China Prostacyclin Drug Sales (2018-2029)
8.1.2 China Prostacyclin Drug Revenue (2018-2029)
8.2 China Prostacyclin Drug Market Size by Application
8.2.1 China Prostacyclin Drug Sales by Application (2018-2029)
8.2.2 China Prostacyclin Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Prostacyclin Drug Market Size by Type
9.1.1 Asia Prostacyclin Drug Sales by Type (2018-2029)
9.1.2 Asia Prostacyclin Drug Revenue by Type (2018-2029)
9.2 Asia Prostacyclin Drug Market Size by Application
9.2.1 Asia Prostacyclin Drug Sales by Application (2018-2029)
9.2.2 Asia Prostacyclin Drug Revenue by Application (2018-2029)
9.3 Asia Prostacyclin Drug Sales by Region
9.3.1 Asia Prostacyclin Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Prostacyclin Drug Revenue by Region (2018-2029)
9.3.3 Asia Prostacyclin Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Prostacyclin Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Prostacyclin Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Prostacyclin Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Prostacyclin Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Prostacyclin Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Prostacyclin Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Prostacyclin Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Prostacyclin Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Prostacyclin Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Prostacyclin Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 United Therapeutics
11.1.1 United Therapeutics Company Information
11.1.2 United Therapeutics Overview
11.1.3 United Therapeutics Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 United Therapeutics Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 United Therapeutics Recent Developments
11.2 Actelion (J & J)
11.2.1 Actelion (J & J) Company Information
11.2.2 Actelion (J & J) Overview
11.2.3 Actelion (J & J) Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Actelion (J & J) Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Actelion (J & J) Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Overview
11.4.3 Teva Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Teva Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Toray
11.5.1 Toray Company Information
11.5.2 Toray Overview
11.5.3 Toray Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Toray Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Toray Recent Developments
11.6 Tide Pharma
11.6.1 Tide Pharma Company Information
11.6.2 Tide Pharma Overview
11.6.3 Tide Pharma Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Tide Pharma Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tide Pharma Recent Developments
11.7 Bayer AG
11.7.1 Bayer AG Company Information
11.7.2 Bayer AG Overview
11.7.3 Bayer AG Prostacyclin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Bayer AG Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prostacyclin Drug Industry Chain Analysis
12.2 Prostacyclin Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostacyclin Drug Production Mode & Process
12.4 Prostacyclin Drug Sales and Marketing
12.4.1 Prostacyclin Drug Sales Channels
12.4.2 Prostacyclin Drug Distributors
12.5 Prostacyclin Drug Customers
13 Market Dynamics
13.1 Prostacyclin Drug Industry Trends
13.2 Prostacyclin Drug Market Drivers
13.3 Prostacyclin Drug Market Challenges
13.4 Prostacyclin Drug Market Restraints
14 Key Findings in The Global Prostacyclin Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Prostacyclin Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Epoprostenol Sodium
Table 3. Major Manufacturers of Treprostinil
Table 4. Major Manufacturers of Iloprost
Table 5. Major Manufacturers of Beraprost Sodium
Table 6. Global Prostacyclin Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Prostacyclin Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Prostacyclin Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Prostacyclin Drug Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Prostacyclin Drug Revenue Market Share by Region (2018-2024)
Table 11. Global Prostacyclin Drug Revenue Market Share by Region (2024-2029)
Table 12. Global Prostacyclin Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Prostacyclin Drug Sales by Region (2018-2024) & (K Units)
Table 14. Global Prostacyclin Drug Sales by Region (2024-2029) & (K Units)
Table 15. Global Prostacyclin Drug Sales Market Share by Region (2018-2024)
Table 16. Global Prostacyclin Drug Sales Market Share by Region (2024-2029)
Table 17. Global Prostacyclin Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Prostacyclin Drug Sales Share by Manufacturers (2018-2024)
Table 19. Global Prostacyclin Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Prostacyclin Drug Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Prostacyclin Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Prostacyclin Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Prostacyclin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Prostacyclin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostacyclin Drug as of 2022)
Table 25. Global Key Manufacturers of Prostacyclin Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Prostacyclin Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Prostacyclin Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 30. Global Prostacyclin Drug Sales by Type (2024-2029) & (K Units)
Table 31. Global Prostacyclin Drug Sales Share by Type (2018-2024)
Table 32. Global Prostacyclin Drug Sales Share by Type (2024-2029)
Table 33. Global Prostacyclin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Prostacyclin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Prostacyclin Drug Revenue Share by Type (2018-2024)
Table 36. Global Prostacyclin Drug Revenue Share by Type (2024-2029)
Table 37. Prostacyclin Drug Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Prostacyclin Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Prostacyclin Drug Sales by Application (2018-2024) & (K Units)
Table 40. Global Prostacyclin Drug Sales by Application (2024-2029) & (K Units)
Table 41. Global Prostacyclin Drug Sales Share by Application (2018-2024)
Table 42. Global Prostacyclin Drug Sales Share by Application (2024-2029)
Table 43. Global Prostacyclin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Prostacyclin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Prostacyclin Drug Revenue Share by Application (2018-2024)
Table 46. Global Prostacyclin Drug Revenue Share by Application (2024-2029)
Table 47. Prostacyclin Drug Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Prostacyclin Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Prostacyclin Drug Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Prostacyclin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Prostacyclin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Prostacyclin Drug Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Prostacyclin Drug Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Prostacyclin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Prostacyclin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Prostacyclin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Prostacyclin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Prostacyclin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Prostacyclin Drug Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Prostacyclin Drug Sales by Country (2024-2029) & (K Units)
Table 62. Europe Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 63. Europe Prostacyclin Drug Sales by Type (2024-2029) & (K Units)
Table 64. Europe Prostacyclin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Prostacyclin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Prostacyclin Drug Sales by Application (2018-2024) & (K Units)
Table 67. Europe Prostacyclin Drug Sales by Application (2024-2029) & (K Units)
Table 68. Europe Prostacyclin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Prostacyclin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Prostacyclin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Prostacyclin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Prostacyclin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Prostacyclin Drug Sales by Country (2018-2024) & (K Units)
Table 74. Europe Prostacyclin Drug Sales by Country (2024-2029) & (K Units)
Table 75. China Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 76. China Prostacyclin Drug Sales by Type (2024-2029) & (K Units)
Table 77. China Prostacyclin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Prostacyclin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Prostacyclin Drug Sales by Application (2018-2024) & (K Units)
Table 80. China Prostacyclin Drug Sales by Application (2024-2029) & (K Units)
Table 81. China Prostacyclin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Prostacyclin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 84. Asia Prostacyclin Drug Sales by Type (2024-2029) & (K Units)
Table 85. Asia Prostacyclin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Prostacyclin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Prostacyclin Drug Sales by Application (2018-2024) & (K Units)
Table 88. Asia Prostacyclin Drug Sales by Application (2024-2029) & (K Units)
Table 89. Asia Prostacyclin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Prostacyclin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Prostacyclin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Prostacyclin Drug Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Prostacyclin Drug Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Prostacyclin Drug Sales by Region (2018-2024) & (K Units)
Table 95. Asia Prostacyclin Drug Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Prostacyclin Drug Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Prostacyclin Drug Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Prostacyclin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Prostacyclin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Prostacyclin Drug Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Prostacyclin Drug Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Prostacyclin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Prostacyclin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Prostacyclin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Prostacyclin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Prostacyclin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Prostacyclin Drug Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Prostacyclin Drug Sales by Country (2024-2029) & (K Units)
Table 109. United Therapeutics Company Information
Table 110. United Therapeutics Description and Major Businesses
Table 111. United Therapeutics Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. United Therapeutics Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. United Therapeutics Recent Developments
Table 114. Actelion (J & J) Company Information
Table 115. Actelion (J & J) Description and Major Businesses
Table 116. Actelion (J & J) Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Actelion (J & J) Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Actelion (J & J) Recent Developments
Table 119. GSK Company Information
Table 120. GSK Description and Major Businesses
Table 121. GSK Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. GSK Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. GSK Recent Developments
Table 124. Teva Company Information
Table 125. Teva Description and Major Businesses
Table 126. Teva Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Teva Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Teva Recent Developments
Table 129. Toray Company Information
Table 130. Toray Description and Major Businesses
Table 131. Toray Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Toray Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Toray Recent Developments
Table 134. Tide Pharma Company Information
Table 135. Tide Pharma Description and Major Businesses
Table 136. Tide Pharma Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Tide Pharma Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Tide Pharma Recent Developments
Table 139. Bayer AG Company Information
Table 140. Bayer AG Description and Major Businesses
Table 141. Bayer AG Prostacyclin Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Bayer AG Prostacyclin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Bayer AG Recent Developments
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Prostacyclin Drug Distributors List
Table 147. Prostacyclin Drug Customers List
Table 148. Prostacyclin Drug Market Trends
Table 149. Prostacyclin Drug Market Drivers
Table 150. Prostacyclin Drug Market Challenges
Table 151. Prostacyclin Drug Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostacyclin Drug Product Picture
Figure 2. Global Prostacyclin Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Prostacyclin Drug Market Share by Type in 2022 & 2029
Figure 4. Epoprostenol Sodium Product Picture
Figure 5. Treprostinil Product Picture
Figure 6. Iloprost Product Picture
Figure 7. Beraprost Sodium Product Picture
Figure 8. Global Prostacyclin Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Prostacyclin Drug Market Share by Application in 2022 & 2029
Figure 10. For Injection
Figure 11. For Oral
Figure 12. For Inhalation
Figure 13. Prostacyclin Drug Report Years Considered
Figure 14. Global Prostacyclin Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Prostacyclin Drug Revenue 2018-2029 (US$ Million)
Figure 16. Global Prostacyclin Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Prostacyclin Drug Revenue Market Share by Region (2018-2029)
Figure 18. Global Prostacyclin Drug Sales 2018-2029 ((K Units)
Figure 19. Global Prostacyclin Drug Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Prostacyclin Drug Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Prostacyclin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Prostacyclin Drug Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Prostacyclin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Prostacyclin Drug Sales YoY (2018-2029) & (K Units)
Figure 25. China Prostacyclin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Prostacyclin Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Prostacyclin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Prostacyclin Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Prostacyclin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Prostacyclin Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Prostacyclin Drug in the World: Market Share by Prostacyclin Drug Revenue in 2022
Figure 32. Global Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Prostacyclin Drug Sales Market Share by Type (2018-2029)
Figure 34. Global Prostacyclin Drug Revenue Market Share by Type (2018-2029)
Figure 35. Global Prostacyclin Drug Sales Market Share by Application (2018-2029)
Figure 36. Global Prostacyclin Drug Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Prostacyclin Drug Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Prostacyclin Drug Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Prostacyclin Drug Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Prostacyclin Drug Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Prostacyclin Drug Revenue Share by Country (2018-2029)
Figure 42. US & Canada Prostacyclin Drug Sales Share by Country (2018-2029)
Figure 43. U.S. Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Prostacyclin Drug Sales Market Share by Type (2018-2029)
Figure 46. Europe Prostacyclin Drug Revenue Market Share by Type (2018-2029)
Figure 47. Europe Prostacyclin Drug Sales Market Share by Application (2018-2029)
Figure 48. Europe Prostacyclin Drug Revenue Market Share by Application (2018-2029)
Figure 49. Europe Prostacyclin Drug Revenue Share by Country (2018-2029)
Figure 50. Europe Prostacyclin Drug Sales Share by Country (2018-2029)
Figure 51. Germany Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 52. France Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 56. China Prostacyclin Drug Sales Market Share by Type (2018-2029)
Figure 57. China Prostacyclin Drug Revenue Market Share by Type (2018-2029)
Figure 58. China Prostacyclin Drug Sales Market Share by Application (2018-2029)
Figure 59. China Prostacyclin Drug Revenue Market Share by Application (2018-2029)
Figure 60. Asia Prostacyclin Drug Sales Market Share by Type (2018-2029)
Figure 61. Asia Prostacyclin Drug Revenue Market Share by Type (2018-2029)
Figure 62. Asia Prostacyclin Drug Sales Market Share by Application (2018-2029)
Figure 63. Asia Prostacyclin Drug Revenue Market Share by Application (2018-2029)
Figure 64. Asia Prostacyclin Drug Revenue Share by Region (2018-2029)
Figure 65. Asia Prostacyclin Drug Sales Share by Region (2018-2029)
Figure 66. Japan Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 70. India Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Prostacyclin Drug Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Prostacyclin Drug Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Prostacyclin Drug Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Prostacyclin Drug Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Prostacyclin Drug Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Prostacyclin Drug Sales Share by Country (2018-2029)
Figure 77. Brazil Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Prostacyclin Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Prostacyclin Drug Value Chain
Figure 83. Prostacyclin Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries